| Honey mediated green synthesis of nanoparticles: new era of safe nanotechnology ER Balasooriya, CD Jayasinghe, UA Jayawardena, RWD Ruwanthika, ... Journal of Nanomaterials 2017 (1), 5919836, 2017 | 194 | 2017 |
| BioID reveals an ATG9A interaction with ATG13‐ATG101 in the degradation of p62/SQSTM1‐ubiquitin clusters AR Kannangara, DM Poole, CM McEwan, JC Youngs, VK Weerasekara, ... EMBO reports 22 (10), e51136, 2021 | 39 | 2021 |
| Landscape of clinical resistance mechanisms to FGFR inhibitors in FGFR2-altered cholangiocarcinoma Q Wu, H Ellis, G Siravegna, AG Michel, BL Norden, F Fece de la Cruz, ... Clinical Cancer Research 30 (1), 198-208, 2024 | 29 | 2024 |
| TNK1 is a ubiquitin-binding and 14-3-3-regulated kinase that can be targeted to block tumor growth TY Chan, CM Egbert, JE Maxson, A Siddiqui, LJ Larsen, K Kohler, ... Nature communications 12 (1), 5337, 2021 | 23 | 2021 |
| SGK2, 14-3-3, and HUWE1 Cooperate to Control the Localization, Stability, and Function of the Oncoprotein PTOV1 KL Pennington, CM McEwan, J Woods, CM Muir, ... Molecular Cancer Research 20 (2), 231-243, 2022 | 7 | 2022 |
| FGFR inhibition blocks NF-ĸB-dependent glucose metabolism and confers metabolic vulnerabilities in cholangiocarcinoma Y Zhen, K Liu, L Shi, S Shah, Q Xu, H Ellis, ER Balasooriya, J Kreuzer, ... Nature Communications 15 (1), 3805, 2024 | 4 | 2024 |
| Generation of a biliary tract cancer cell line atlas reveals molecular subtypes and therapeutic targets V Vijay, N Karisani, L Shi, YH Hung, P Vu, P Kattel, L Kenney, J Merritt, ... bioRxiv, 2024 | 2 | 2024 |
| Integrating clinical cancer and PTM proteomics data identifies a mechanism of ACK1 kinase activation ER Balasooriya, D Madhusanka, TP López-Palacios, RJ Eastmond, ... Molecular Cancer Research 22 (2), 137-151, 2024 | 2 | 2024 |
| The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations ER Balasooriya, Q Wu, H Ellis, Y Zhen, BL Norden, RB Corcoran, ... Clinical Cancer Research 30 (10), 2181-2192, 2024 | 1 | 2024 |
| Elucidation of a unique regulatory mechanism for TNK1 provides potential therapeutic targeting opportunities in cancer TY Chan, C Egbert, L Larsen, J Tsang, J Maxson, E Roshan, CJ Whatcott, ... Cancer Research 81 (13_Supplement), 2307-2307, 2021 | 1 | 2021 |
| 14-3-3 binding stabilizes and sequesters PTOV1 to the cytoplasm during G1 K Pennington, C McEwan, J Woods, C Muir, AGP Sahankumari, ... Journal of Biological Chemistry 299 (3), 104286, 2023 | | 2023 |
| 14-3-3 binding during G1 stabilizes and sequesters PTOV1 to the cytoplasm KL Pennington, CM McEwan, J Woods, CM Muir, AGP Sahankumari, ... Cancer Research 82 (12_Supplement), 1469-1469, 2022 | | 2022 |
| A mechanism of ACK1 activation in cancer via C‐terminal UBA domain truncation E Balasooriya, R Eastmond, D Madusanka, J Owen, J Gashler, ... The FASEB Journal 36, 2022 | | 2022 |
| The ubiquitin-binding non-receptor tyrosine kinase TNK1 is regulated by a MARK-mediated interaction with 14-3-3 CM Egbert, TY Chan, L Larsen, ER Balasooriya, K Kohler, J Tsang, ... Cancer Research 81 (13_Supplement), 2306-2306, 2021 | | 2021 |
| Regulation of the oncogenic tyrosine kinase ACK1 through ubiquitin-dependent mechanism ERBL Balasooriyage, J Owen, J Gashler, C Muir, K Pennington, J Moody, ... Cancer Research 81 (13_Supplement), 2304-2304, 2021 | | 2021 |
| 14-3-3zeta Role in Promoting Survival of Cells to Facilitate Progression of Cancer K Pennington, E Roshan, J Andersen, KK McCormack | | 2018 |
Chanika D JayasingheDeparment of Zoology The Open University of Sri Lankaou.ac.lk의 이메일 확인됨